Biotech | January 04, 2022
Yokogawa invests in glycan production company GlyTech
Partnering to build biosynthesis processes and a pharmaceutical production platform
Partnering to build biosynthesis processes and a pharmaceutical production platform
Zeebon is the largest diagnostics services provider in North-Eastern states
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
FDA changes inspection classification of the facility to Voluntary Action Indicated
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
The union health ministry notifies the protocol and this move will also help in organ donation
Subscribe To Our Newsletter & Stay Updated
